대한부인종양학회

최신 논문

총 게시글 : 136

Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer 2025-06-23 VIEW : 10
Tegafur-uracil maintenance chemotherapy post-chemoradiotherapy for cervical cancer: Randomized trial 2025-06-23 VIEW : 2
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial 2025-06-23 VIEW : 9
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial 2025-06-23 VIEW : 2
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial 2025-06-23 VIEW : 4
An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment 2025-06-23 VIEW : 5
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy: The POLAR Randomized Clinical Trial 2025-06-23 VIEW : 3
Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks 2025-06-23 VIEW : 5
Oncological outcomes, surgical margins, and adjuvant treatment delays in vulvar cancer patients with or without reconstruction during primary surgery 2025-06-23 VIEW : 4
Reduced symptoms of late radiation tissue injury of the vagina after treatment with hyperbaric oxygen therapy: A retrospective analysis of 19 patients 2025-06-23 VIEW : 4
PD-L1-Expression in primary and recurrent vulvar squamous cell cancer 2025-03-20 VIEW : 32
Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study 2025-03-20 VIEW : 10
What happens after menopause? (WHAM): A prospective controlled study of cognition 24 months after premenopausal risk-reducing salpingo-oophorectomy 2025-03-20 VIEW : 9
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results 2025-03-20 VIEW : 25
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial 2025-03-20 VIEW : 7

1
2
3
4
5
6
7
8
9
10